CLINICAL_TRIALS
trial_result
· 2011-11-08
Clinical Trial Update: Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet [Phase 1, Phase 2]
Summary
A completed Phase 1/2 clinical trial evaluating etanercept (Enbrel) for psoriasis of the hands and/or feet.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, Irvine | Conditions: Psoriasis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-11-08